REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biogened S.A. (Poland)

Main Activities: Pharmaceutical and Medicine Manufacturing | Cosmetics, Beauty Supplies, and Perfume Stores
Full name: Biogened S.A. Profile Updated: October 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Biogened is a research company. The company focuses on developing therapeutic cosmetic products for international markets. Their main business is the development of cosmetic products using Omega 3.6 ethyl esters.

Headquarters
ul. Pojezierska 99
Lodz; Lodzkie; Postal Code: 91-342

Contact Details: Purchase the Biogened S.A. report to view the information.

Website: http://www.biogened.pl

Basic Information
Total Employees:
Purchase the Biogened S.A. report to view the information.
Outstanding Shares:
Purchase the Biogened S.A. report to view the information.
Registered Capital:
Purchase the Biogened S.A. report to view the information.
Financial Auditors:
Purchase the Biogened S.A. report to view the information.
Incorporation Date:
February 01, 2007
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
40.9%
Purchase this report to view the information.
36.93%
Purchase this report to view the information.
16.28%
Company Performance
Financial values in the chart are available after Biogened S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
20.37%▲
Total operating revenue
19.98%▲
Operating profit (EBIT)
9.44%▲
EBITDA
12%▲
Net Profit (Loss) for the Period
7.52%▲
Total assets
11.53%▲
Total equity
11.77%▲
Operating Profit Margin (ROS)
-1.18%▼
Net Profit Margin
-0.74%▼
Return on Equity (ROE)
-0.38%▼
Debt to Equity Ratio
-0.17%▼
Quick Ratio
-0.33%▼
Cash Ratio
0.02%▲

Similar companies

Zaklady Farmaceutyczne "Polpharma" S.A.
 
Lek S.A.
Bayer Sp. z o.o.
 
"Roche Polska" Sp. z o.o.
Teva Operations Poland Sp. z o.o.
 
Adamed Pharma S.A.
Synoptis Industrial Sp. z o.o.
 
"Symphar" Sp. z o.o.
Master Pharm S.A.
 
Exim Pharma Sp. z o.o.
Exeltis Poland Sp. z o.o.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo